Associations between Plasma Cytokines and Depressive Mood in Patients with Breast Cancer
Authors:
- Sung-Wan KimSKSung-Wan Kim
- Il-Seon ShinISIl-Seon Shin
- Min-Ho ParkMPMin-Ho Park
- Jung-Han YoonJYJung-Han Yoon
- Chan ChoiCCChan Choi
- Jin-Sang YoonJYJin-Sang Yoon
- 1 January 2012
- journal article
- research article
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 43 (1) , 1-17
Abstract
Objective: The few studies on the associations between cytokines and depressive mood in patients with cancer have produced conflicting results. This study investigated the associations between plasma cytokines and depressive mood in patients with breast cancer using a large panel of pro-inflammatory, anti-inflammatory, and immune-modulating cytokines. Methods: We recruited 273 hospitalized patients with breast cancer awaiting surgery. Preoperative plasma samples were obtained for cytokine analysis, including pro-inflammatory (interleukin [IL]-2, IL-12, interferon [IFN]-γ, and tumor necrosis factor [TNF-α]), anti-inflammatory (IL-4, IL-5, IL-10, and IL-13), and immune-modulating (granulocyte/macrophage colony-stimulating factor [GM-CSF]) cytokines. Depressive mood was measured using the Montgomery—Asberg Depression Rating Scale (MADRS) at 2–5 days postoperatively, when the patients could cooperate. Covariates included various demographic and clinical characteristics. The association between the MADRS score and each cytokine level was estimated using linear regression models. Results: Cytokine levels were significantly inter-correlated. Depressive mood was associated with lower levels of pro-inflammatory (IL-2, IL-12, and TNF-α), anti-inflammatory (IL-5, IL-10, and IL-13), and immune-modulating (GM-CSF) cytokines independent of potential covariates such as living area or functional level. Conclusions: The findings suggest that depressive mood is associated with a generally decreased inflammatory reaction or immune function in patients with breast cancer.Keywords
This publication has 40 references indexed in Scilit:
- Decrease in Depression Symptoms Is Associated With Longer Survival in Patients With Metastatic Breast Cancer: A Secondary AnalysisJournal of Clinical Oncology, 2011
- Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategiesNeurobiology of Disease, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Positive affect and inflammation during radiation treatment for breast and prostate cancerBrain, Behavior, and Immunity, 2009
- Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory studyJournal of Psychosomatic Research, 2009
- Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patientsBrain, Behavior, and Immunity, 2008
- Immunotherapy of cancer by IL-12-based cytokine combinationsExpert Opinion on Biological Therapy, 2007
- Stress and depression-induced immune dysfunction: Implications for the development and progression of cancerInternational Review of Psychiatry, 2005
- Depression as a Prognostic Factor for Breast Cancer MortalityPsychosomatics, 2003
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979